Biotech Startups

Plantner extracts and manufactures alginate, a biodegradable material used across biomedical and industrial applications. Its alginate is applied in medical devices, pharmaceuticals, cosmetics, advanced biotech (such as bio-ink and organoids), and agriculture.

1 investor

PlantSustain develops biological crop inputs using naturally symbiotic bacteria and fungi to replace chemical fertilizers and pesticides, aiming to improve plant health, resilience, and nutrient uptake for farmers. It commercializes biological innovation from research institutions and universities for the agriculture industry.

1 investor

PLAS-FREE develops medical devices that remove specific substances from blood products to treat life-threatening conditions such as hemorrhage and hepatic encephalopathy. The company targets hospitals and blood transfusion centers with devices designed for emergency and critical care settings.

1 investor

PlasmaGen BioSciences is a biopharmaceutical company focused on plasma protein and specialty care therapies, offering products across medical specialities such as neurology, haematology, oncology, immunology and critical care. It serves patients in India and other developing economies, working with government bodies on affordability, accessibility and hemovigilance.

1 investor

Plasmidsaurus provides fast DNA and RNA sequencing services for scientists, including whole plasmid, whole genome, amplicon, microbiome, RNA-Seq, and AAV sequencing, with bioinformatics tools and annotated data delivered overnight. It serves academic researchers, pharma companies, and life-science labs, offering sample submission via a global network of dropboxes.

1 investor

1 investor

Plaxin develops a bioplastic material designed as an alternative to conventional plastic to address environmental concerns. The company focuses on producing sustainable materials for industrial applications.

1 investor

Play Health builds a clinical decision-support platform for healthcare providers to deliver personalized menopause and women's health care. The platform serves primary care physicians and other providers treating women navigating perimenopause and menopause.

1 investor

A regenerative medicine company developing platform technologies and products for the bio and medical regeneration industry, applying research in skin and tissue regeneration to improve quality of life. Its work is led by plastic surgery clinical and research faculty.

1 investor

Pleioflow develops minimally invasive flow assist devices designed to prevent renal failure in cardiac surgery patients and those experiencing acute kidney injury. The company focuses on medical devices for cardiac assist and renal protection applications.

1 investor

PlenaryAI builds customized artificial intelligence tools for physicians and clinical staff, combining biomarkers and multi-modality imaging with data analytics to support clinical decisions for patients. The company focuses on precision health for the biomedical and healthcare sector.

1 investor

Pleural Dynamics makes ACES (Automatic Continuous Effusion Shunt), an FDA-cleared minimally invasive implant that uses the body's breathing motion to move pleural fluid from the lungs to the abdomen for reabsorption. The device treats patients with recurrent pleural effusions caused by cancer, heart failure, or infection, offering an alternative to pleural catheters and pleurodesis.

1 investor

SpeeDx provides multiplexing technology platforms and diagnostic assays for detecting infectious disease pathogens, including customized solutions for respiratory infections, sexually transmitted infections, gastrointestinal illness, and antimicrobial resistance markers. The company serves laboratories, diagnostic companies, biotechs, and pharmaceutical firms through technology licensing, custom assay development, and partnership services.

1 investor

Pliant Therapeutics is a clinical-stage biopharmaceutical company developing integrin-based therapeutics to treat serious diseases. The company focuses on understanding integrin biology and molecular mechanisms of pathology to create safer and more effective therapies for patients.

1 investor

PLT develops human tissue organoids produced in microgravity conditions for use in pharmaceutical testing, precision medicine, and transplantation research. The company manufactures these 3D tissue cultures from stem cells and is developing hardware for commercial-scale organoid production in space.

1 investor

Plurify develops manufacturing technology for advanced therapies, specifically cell and gene therapy production. The company's platform addresses scalability, safety, and cost challenges in bioreactor-scale therapeutic manufacturing.

1 investor

Pluvia Biotech is a University of Bergen spin-out developing small molecule pharmacological chaperones that stabilize and correct misfolded proteins to rescue enzymatic activity in rare genetic loss-of-function disorders. Its lead program, PBAS499, targets phenylketonuria (PKU), an inborn metabolic disorder, with plans to apply its drug discovery platform to other protein-misfolding diseases.

1 investor

1 investor

1 investor

Polari Group is a biotech company focused on infectious disease research and product development, leveraging scientific expertise in virology, bioengineering, and microfluidics.

1 investor

Polari Labs develops A-BALL, a body-safe insertable device positioned as an alternative to anal douching that acts as a barrier and dissolves into a stool-like texture for later removal. The company is building a lab focused on the science of anal intimacy products, based in London.

1 investor

Polaris Partners is an investment firm with nearly 30 years of experience backing healthcare and biotech companies, focusing on innovative care delivery, digital health, consumer-centric businesses, therapeutics, and genomics.

1 investor

POLBIOTECH LABORATORIUM provides biotechnological monitoring and analysis services for biogas plants, helping operators optimize methane fermentation processes through accredited lab testing and expert consulting. The company serves biogas facility managers and developers in Poland with sample analysis, production forecasting, and operational problem-solving.

1 investor

Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases. Its lead program pursues disease-modifying treatments for tauopathies and related conditions such as Parkinson's disease, starting with orphan tauopathy indications.

1 investor